Calamine: Package Insert and Label Information

CALAMINE — ferric oxide red and zinc oxide lotion
Dolgencorp, LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active ingredients

Calamine 8%
Zinc oxide 8%

Purpose

skin protectant

Use

dries the oozing and weeping of poison:•ivy • oak • sumac

Warnings

For external use only

When using this product

do not get into eyes

Stop use and ask a doctor if

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again wthin a few days

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away

Directions

• shake well before using • apply as needed

Other information

store at 59⁰ — 86⁰ F

Inactive ingredients

bentonite magma, calcium hydroxide, glycerin, purified water

Visit us at: Rexall.com

or call 1-866-4REXALL
DISTRIBUTED BY DOLGENCORP, LLC

100 MISSION RIDGE

GOODLETTSVILLE, TN 37072 USA

063.001/063AA

principal display panel

Since 1903
REXALL

Calamine Lotion
Calamine Topical Suspension USP
• Poison ivy, oak and sumac drying lotion
• Skin protectant

6 FL OZ (177 mL)

image description
(click image for full-size original)
CALAMINE
ferric oxide red lotion
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:55910-063
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FERRIC OXIDE RED (FERRIC OXIDE RED) FERRIC OXIDE RED 80 mg in 1 mL
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE 80 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
bentonite
CALCIUM HYDROXIDE
GLYCERIN
water
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:55910-063-30 177 mL in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part347 04/13/2009
Labeler — Dolgencorp, LLC (068331990)
Registrant — Vi Jon (790752542)
Establishment
Name Address ID/FEI Operations
Vi Jon 790752542 manufacture (55910-063)

Revised: 06/2020 Dolgencorp, LLC

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.